Universal Coverage, Institutional Design And Fiscal Discipline: Reflections On The Chinese National Health Insurance Model
- 6 days ago
- 16 min read
Read the full journal, including this article, by downloading the PDF below.
Image credit: AI-generated illustration produced with OpenAI (DALL·E), 2026.
by Daryl Swanepoel
Abstract
South Africa’s National Health Insurance (NHI) reform represents a major institutional restructuring aimed at achieving universal access to quality healthcare. While the principle of universal coverage is constitutionally grounded and widely supported, debate centres on system design, fiscal sustainability and governance resilience. At the time of writing, the NHI Act is subject to Constitutional Court scrutiny, with challenges focusing on financing feasibility, governance concentration and the restriction of private medical schemes. In this context, comparative analysis is instructive.
This paper examines China’s national health insurance architecture as a reference point. Over three decades, China has expanded basic medical insurance coverage to approximately 95% of its population through a layered, contributory and fiscally bounded system. Rather than relying on a single exclusive fund, China operates multiple core insurance schemes supplemented by municipal add-ons and commercial private cover. Benefits are defined, contributions are structured and cost control mechanisms, including Diagnosis-Related Group payment models and volume-based procurement, are embedded in the financing framework.
While China’s political system differs markedly from South Africa’s, its institutional design choices highlight key principles: layered risk pooling, bounded benefits, contribution discipline and sequencing clarity. Universal coverage, the paper argues, is ultimately an institutional design challenge requiring fiscal realism alongside social solidarity.
Keywords: National Health Insurance (NHI), Universal Health Coverage, China Healthcare System, Healthcare Financing, Institutional Design
Introduction: Why study China now?
South Africa stands at a pivotal moment in the reform of its healthcare system. The National Health Insurance (NHI) Act has been signed into law, and the country now faces the practical question of how such a system is to be structured, financed and implemented. The aspiration underlying the Act, universal access to affordable, quality healthcare, is not controversial in principle; instead, it is grounded in constitutional commitment (RSA, 1996) and in a broadly shared moral conviction that healthcare should not be determined by income alone.
The debate in South Africa is therefore not fundamentally about whether universal health coverage is desirable. It is about design. It is about sequencing. It is about institutional resilience.
Several structural concerns have crystallised in public debate and in legal challenges currently before the Constitutional Court. The proposal to concentrate healthcare purchasing authority in a single national fund has raised questions of systemic concentration risk. Critics ask whether placing the entirety of national health financing under one institutional roof introduces vulnerability in the event of governance failure, fiscal miscalculation or administrative incapacity, and in a country that has witnessed the fragility of concentrated public monopolies in other sectors, this concern resonates widely (Stokes, 2026; Jeffery, n.d.).
A second issue relates to the Act’s restriction of private medical schemes to mere complementary cover. South Africa presently operates a dual system in which private medical aids and private hospitals function alongside a tax-funded public health sector, but the envisaged NHI framework signals a shift toward exclusivity, by limiting the role of private schemes in areas covered by the national fund. The implications of such limitation for investment, choice, specialist retention and system resilience remain intensely debated (Jeffery, n.d.).
Thirdly, the governance architecture has come under scrutiny, in that the concentration of appointment and oversight powers within the executive has raised questions about whether there are sufficient checks and balances, and it is further argued that the durability of any large-scale social insurance system cannot depend only on actuarial soundness, but also on the system’s institutional credibility across political cycles (Jeffery, n.d.).
These structural concerns are compounded by the absence of a consolidated, costed financing white paper that details revenue instruments, contribution rates, transitional costs, and the long-term actuarial modelling that will be applied (Stokes, 2026). During prior consultations between the Inclusive Society Institute and the Department of Health, it was suggested that implementation may proceed incrementally “as finances permit” (Swanepoel, 2026). While phasing is common in major reform, open-ended finance-contingent rollout introduces sequencing risk. Universal insurance reform restructures institutional arrangements in ways that are not easily reversible.
It is important to note that South Africa does not approach universal healthcare from a position of absence. A large proportion of the population already enjoys access to public healthcare services that are free at the point of use (Baugh, n.d.). In this respect, there are superficial similarities with earlier models of low-cost or state-supported access observed in other systems. However, international experience suggests that the sustainability of such arrangements depends not on access provisions alone, but also on the alignment between funding, institutional capacity and provider incentives. Where this alignment is weak, access may remain formally available, but system performance deteriorates.
This aligns with a broader body of health systems literature that emphasises that universal coverage outcomes depend largely on the coherence between the financing arrangements underpinning the system, as well as the incentives given to providers and the capacity of the institutions (World Bank, 2016; Yip et al., 2019). The central challenge is therefore not only to expand access to healthcare, but also to ensure that the underlying arrangements are capable of sustaining the system (Leng, 2026). Financing clarity, therefore, is not peripheral; it is foundational.
A further dimension, insufficiently developed in current debates, concerns the relationship between insurance design and the underlying economics of healthcare provision. International experience suggests that large-scale insurance reforms cannot be assessed in isolation from hospital financing models, service pricing structures and provider remuneration systems. Where these elements are misaligned, systemic pressures may emerge irrespective of the formal design of the insurance mechanism itself. In the South African context, limited clarity has thus far been provided on how public hospital funding, tariff setting and practitioner incentives will evolve alongside the implementation of the NHI. Without parallel reform in these areas, the risk arises that financial strain and incentive distortions may undermine system performance, even if the insurance architecture is conceptually sound.
It is within this context that the Inclusive Society Institute has embarked on a series of comparative country studies. This China study (Beijing Dialogue) constitutes the first in a structured series of country analyses, to be followed by field studies of Finland and Thailand, before a consolidated comparative synthesis is produced. The purpose is not to advocate transplantation. South Africa’s constitutional, fiscal and administrative environment is unique. Rather, the purpose is diagnostic: to examine how countries with different political systems and developmental trajectories have structured universal coverage, managed financing risk, and navigated the relationship between public and private provision.
China offers a particularly instructive case. It is neither a small welfare state, nor a conventional liberal democracy; it is a vast and administratively complex polity that has expanded health insurance coverage to approximately 95% of its population over the past three decades (PRC, 2024). Its governance model differs profoundly from that of South Africa, but it has confronted challenges common to all systems pursuing universal coverage: fiscal sustainability, cost control, rural inclusion, hospital reform and the role of private finance.
The Chinese experience is therefore examined here as a reference point. It allows us to explore how universal coverage can be structured at scale, what financing disciplines underpin it, and how layered insurance mechanisms function within a national framework.
Historical evolution: From state provision to contributory insurance
China’s contemporary health insurance system did not emerge fully formed; instead, it evolved. Prior to the mid-1990s, healthcare provision was largely state funded within a centrally planned economy. However, as market reforms deepened in China, the limitations of a purely budget-funded healthcare system became apparent; and in the wake of rising costs, demographic shifts and economic liberalisation, the necessary pressure was created to move towards a more structured insurance model that was capable of funding the healthcare system within the changing environment (Swanepoel, 2026).
The reform process is commonly associated with a number of critical milestones, the first of which began in 1989, when China initiated pilot reforms of the medical insurance system. Contributory model pilots were introduced in 1994, followed by the formal establishment of the Basic Medical Insurance system for Urban Employees in 1998. In 2003, rural cooperative medical schemes were expanded significantly in order to address the gaps in coverage of those who found themselves outside the formal urban workforce. And in 2007, the Urban Resident Basic Medical Insurance scheme was introduced, which scheme extended coverage to non-employed urban populations, thereby closing a critical gap in the emerging system.
By 2008, coverage had expanded rapidly across both urban and rural populations, extending access across both geographic and income divides, with institutional integration between urban and rural resident schemes formally achieved through the 2016 reform (Leng, 2026; Swanepoel, 2026).
Subsequent reforms consolidated fund administration under the National Healthcare Security Administration, which strengthened cost-control mechanisms that international observers have described as being incremental but expansive, given that it combined rapid coverage growth with evolving institutional reform (World Bank, 2016; Yip et al., 2019).
What is notable about this historical arc is not simply the speed of expansion, but also the consistent embedding of financing parameters at each stage, with reform phases not framed as open-ended entitlement expansions. They were accompanied by defined contribution structures, reimbursement rules and cost-management mechanisms.
Architecture of coverage: A layered system, rather than a monolith
China’s health insurance system is often colloquially described as “national”. Yet the Beijing consultations revealed a more nuanced architecture. The system operates across multiple layers.
At its foundation are two principal social insurance schemes. The Urban Employee Basic Medical Insurance covers formally employed workers. Contributions are salary-linked, with employees contributing approximately 2% of their income and employers contributing a significantly larger amount, typically between 6% and 8%. The payroll-based structure anchors the system in contributory discipline (Swanepoel, 2026).
The Urban and Rural Resident Basic Medical Insurance also covers individuals who work outside of formal employment. These participants contribute an annual premium commonly reported at several hundred renminbi, while central and local governments provide substantial subsidies (Swanepoel, 2026).
Vulnerable groups, including the elderly and low-income citizens, may have their premiums fully subsidised by government programmes (Swanepoel, 2026).
These two schemes form the core layer, covering the vast majority of the population, but coverage under these schemes is not unlimited, and reimbursement levels vary according to the level of hospital and the nature of care. Primary facilities may see high reimbursement ratios, whereas tertiary hospitals, which provide specialised and advanced services, often reimburse approximately half to sixty percent of costs, with the remainder covered by the individual or supplementary insurance (Swanepoel, 2026).
Above this foundational layer sit supplementary mechanisms such as municipal insurance products like “Huimin Bao”, which offers inexpensive add-on coverage designed to absorb the costs attached to catastrophic or high-cost treatments that are not fully covered under the core scheme. In addition, critical illness insurance cover and emerging long-term care insurance products further extend protection against specific risk categories (Swanepoel, 2026).
Finally, fully commercial private insurance products operate alongside the public system, and these products typically cover innovative therapies, advanced pharmaceuticals, enhanced service options and VIP facilities. Furthermore, it is important to note that private insurance is not prohibited and that it functions as a complement to the public scheme (Swanepoel, 2026).
The overall structure of the health system is therefore layered, rather than monolithic, whereby universal coverage exists within a framework that accommodates both supplementary and private financing.
Financing discipline: Contributions, co-payments and cost controls
Three features of the Chinese system stand out in financing terms: contribution discipline, bounded benefits and active cost control.
First, the system is contributory. Even residents outside formal employment contribute defined premiums, albeit subsidised. The principle that beneficiaries contribute something toward the system, either directly or through payroll, is embedded structurally (Swanepoel, 2026).
This contribution culture mitigates the perception of unlimited entitlement.
Second, benefits are bounded. China operates defined reimbursement lists for medicines and treatments, meaning that only items included on approved lists are reimbursed through the social insurance scheme. Therapies outside the list may require out-of-pocket payment or private insurance. The benefit package is therefore best described as being circumscribed, rather than being open-ended (Swanepoel, 2026).
Third, cost control mechanisms are integral to the system, where the Diagnosis Related Group (DRG) payment models increasingly govern hospital reimbursement, by establishing fixed payments per case. Hospitals that deliver care below the benchmark retain efficiencies; those exceeding the benchmark share in losses. In this manner, incentives are shifted away from pure fee-for-service escalation (Swanepoel, 2026).
Volume-based pharmaceutical procurement is another key mechanism, best illustrated through the leveraging of its national purchasing power, where authorities negotiate bulk agreements with drug manufacturers, which has resulted in significant price reductions in many categories (Swanepoel, 2026).
This strategic purchasing reflects an understanding that universal coverage must be accompanied by aggressive expenditure management, and together, these mechanisms suggest a coherent fiscal philosophy, which is that solidarity must operate within financial constraints.
While these features of the insurance architecture are central to the system’s performance, they do not operate in isolation. The evolution of China’s medical insurance system has been closely intertwined with broader reforms in hospital financing, service pricing and provider remuneration.
Under earlier reform phases, public hospitals were permitted to rely on drug mark-ups to sustain operations, but this particular mechanism was later removed as part of cost-control efforts. However, the removal of the drug mark-up mechanism required compensating adjustments in other areas, including increased government funding, the recalibration of medical service prices and reforms to physician remuneration structures; and when such adjustments did not keep pace, financial pressures on hospitals and distortions in provider incentives emerged. This illustrates that the sustainability of the insurance system is not only contingent on its internal design, but equally so on its alignment with the wider political economy of healthcare provision (Leng, 2026).
Governance structure: Administrative separation within Executive Authority
The governance of the Chinese healthcare system is administratively structured, with the National Health Commission overseeing the healthcare delivery standards and regulatory matters, and the National Healthcare Security Administration managing insurance financing and the funding of operations. Pharmaceutical regulation, in turn, falls under separate administrative authority (Swanepoel, 2026).
Appointments are executive in character, reflecting China’s governance model. Oversight ultimately flows through governmental reporting structures, rather than through parliamentary separation as found in liberal democracies.
Yet, functional separation between service regulation and fund administration exists. The insurance authority focuses on financing, reimbursement and cost control, while health commissions oversee clinical standards and institutional performance (Swanepoel, 2026).
This administrative segmentation does not mirror South Africa’s constitutional framework. Nonetheless, it demonstrates that large-scale national insurance systems may divide operational functions, even within centralised governance models.
Public and private provision: Coexistence and accreditation
China’s hospital landscape is dominated by public institutions, particularly the tertiary academic hospitals, which carry the majority of complex caseloads. But that said, private hospitals exist in substantial numbers, and they often focus on specialised or elective services (Swanepoel, 2026).
Doctors employed in public hospitals may also practise part time in private facilities if they so wish. Accredited private hospitals may accept social insurance reimbursement, provided they meet prescribed standards. Facilities that fail to meet standards may not access public insurance reimbursement; they are, however, allowed to continue operating, provided they are properly licensed (Swanepoel, 2026).
Importantly, this coexistence is not limited to complementary or innovative services only; accredited private hospitals may provide procedures that are included in the public reimbursement list. Moreover, social insurance covering the eligible portion of the cost may be claimed, with patients settling the remaining co-payment through out-of-pocket expenditure or supplementary insurance. Private insurance may in turn cover the portion of the co-payment already included in the public scheme, as well as the additional financing required to fund enhanced service levels. This therefore suggests that the relationship between public and private financing is one that overlaps, rather than being mutually exclusive (Swanepoel, 2026).
This accreditation mechanism reinforces quality oversight while permitting ownership diversity. The insurance fund contracts with all providers are based on standards, regardless of ownership form.
Regional variation and local fund capacity
Although described as national, China’s system exhibits regional variation, in that reimbursement ratios may differ across cities depending on local fund capacity; wealthier regions may sustain higher reimbursement levels, whereas less affluent regions may impose greater cost sharing (Swanepoel, 2026).
This partial decentralisation reflects fiscal realities within a large and diverse country, and it also introduces an element of distributed risk, as financing is not entirely homogenised across all regions.
Implementation and sequencing
China’s universal coverage did not emerge through abrupt structural overhaul. Instead, reform phases were incremental, but defined, with each expansion stage accompanied by the introduction of specified contribution rates and reimbursement parameters (Swanepoel, 2026).
The sequencing appears deliberate in that the financing architecture was articulated alongside expansion in coverage, meaning that reform did not proceed on an open-ended “as finances permit” basis; instead, it was embedded within clearly defined fiscal parameters (Swanepoel, 2026).
International assessments emphasise that while challenges remain, China has combined coverage expansion with continuous cost management and institutional strengthening (Yip et al., 2019).
Strengths and tensions within the model
The Chinese model’s strengths include near-universal coverage, defined contribution structures, layered financing and embedded cost control mechanisms. The coexistence of private insurance and public coverage introduces risk buffering and service diversity.
However, tensions between the private and public systems remain, regional disparities in reimbursement persist, and the integration of health records and insurance databases continues to evolve.
Public hospitals dominate specialised care, potentially limiting competitive dynamics, and governance remains executive-centric.
Yet the structural logic is coherent: universal coverage is pursued within contributory discipline and bounded fiscal commitment.
Analytical reflections
The Chinese experience illustrates several broader design principles.
Universal coverage does not require elimination of supplementary or private insurance. Layered risk pooling can coexist with solidarity.
Cost control must be systemic, rather than reactive, and therefore DRGs, procurement negotiation and reimbursement lists are not peripheral features; they are, indeed, foundational.
Contribution discipline reinforces sustainability. Even modest premiums create a participatory financing culture.
Sequencing matters, and as such, financing parameters tend to accompany expansion rather than follow it.
These observations do not imply transplantation, but instead they provide comparative insight. In evaluating any national insurance reform, key questions arise, namely: How is risk distributed? How is concentration mitigated? How are incentives structured? How is financing defined before structural consolidation proceeds?
China’s system reflects one coherent set of answers. It demonstrates that universalism and plurality need not be in tension. It shows that solidarity can operate within layered financing. It confirms that cost discipline is inseparable from coverage ambition.
Comparative reflections: Institutional design and ongoing legal scrutiny
The relevance of the Chinese experience does not lie in its political structure, nor in the scale of its economy, but in the institutional design questions it surfaces, and when placed alongside South Africa’s current reform trajectory, certain analytical observations emerge.
At the time of writing this report, the National Health Insurance Act is under judicial review in the Constitutional Court of South Africa. Cases have been brought challenging the rationality of the President’s decision to assent to the Act, and questions are being raised about the National Insurance Fund’s governance design, its financing feasibility and its constitutional compliance (Business Day, 2026). The litigation also raises questions relating to the Fund’s governance structure, the concentration of financial authority, the restriction of private medical schemes, and the broader rationality and feasibility of the financing model. These Constitutional Court proceedings form part of the wider policy context within which universal healthcare reform is being assessed in South Africa.
Against this backdrop, the Chinese case does not necessarily offer South Africa a template that can be duplicated wholesale, but it does serve to illuminate how another large and complex society has navigated similar structural questions to those confronting the country.
One of the central issues in South Africa concerns the concentration of purchasing authority within a single national fund. China's system, while nationally coordinated, operates through layered mechanisms, whereby the core social insurance schemes are complemented by supplementary municipal insurance products and fully commercial private cover; reimbursement ratios, in turn, vary across regions, thereby reflecting local fund capacity. In effect, risk is not absorbed through a singular exclusive channel but distributed across a structured set of financing tiers, and while this does not eliminate fiscal pressure, it does create buffers.
A second concern in South Africa relates to the restriction of private medical schemes to complementary services. In China, private insurance was not dismantled during the expansion of universal coverage; on the contrary, supplementary and commercial insurance products play a defined role, particularly in covering innovative therapies and higher service levels. Universalism, in this context, did not require exclusivity. It required delineation.
Governance architecture also differs markedly. China’s appointments are executive in character, reflecting its political structure. Yet operational responsibilities are institutionally divided between healthcare regulation and insurance fund administration.
Functional segmentation exists even within centralised governance. While South Africa’s constitutional framework is distinct, the broader principle that financing administration and healthcare oversight may be separated is evident.
Perhaps most significant for present purposes is the question of sequencing. China’s reform phases were accompanied by defined contribution structures, reimbursement parameters and cost-control mechanisms. Coverage expansion was embedded within articulated financing architecture. Reform did not proceed on an undefined “as finances permit” basis; rather, fiscal parameters were clarified alongside structural rollout. The implication is not that financing challenges disappear, but that clarity precedes consolidation.
These observations do not resolve South Africa’s debate. They do, however, demonstrate that universal coverage elsewhere has been constructed through layered financing, bounded benefit packages and institutionalised cost discipline, rather than through singular institutional concentration.
For South Africa, where universal access remains a legitimate national aspiration, the enduring design question is not whether coverage should expand, but how institutional resilience, fiscal clarity and risk distribution are embedded at the outset.
Conclusion
China’s national health insurance architecture is best understood not as a single centralised fund, but as a layered, contributory and bounded system that has evolved over three decades. Coverage is broad, but not unlimited. Private insurance remains operative. Cost control is institutionalised. Reform has been phased and parameter-defined.
The model is embedded within China’s political and administrative context and cannot be transposed wholesale. Yet its structural features — layered financing, contribution discipline, defined reimbursement and coexistence with private provision — offer valuable comparative insights for any middle-income country contemplating large-scale health insurance reform.
The comparative evidence suggests that universal coverage is not secured through financing architecture alone, but also through the alignment of insurance mechanisms with the broader economics of healthcare provision, including hospital funding models, service pricing and provider incentives.
Universal access is a legitimate aspiration; the enduring question is how to design institutions capable of sustaining it.
References
Baugh, E. n.d. The Healthcare System in South Africa. International Citizens Insurance. [Online] Available at: https://www.internationalinsurance.com/countries/south-africa/healthcare/ [accessed: 8 April 2026].
Jeffery, A. n.d. National Health Insurance: Another taxing state-owned monopoly. [Online] Available at: https://beweging.co.za/wp-content/uploads/2023/12/NHI-Another-taxing-state-owned-monopoly.pdf. [accessed: 20 February 2026].
Kahn, T. 2026. Constitutional Court defers case over Ramaphosa’s NHI Act assent. [Online] Available at: https://www.businessday.co.za/news/health/2026-02-11-constitutional-court-defers-case-over-ramaphosas-nhi-act-assent/ [accessed: 19 February 2026].
Leng, Z. 2026. Personal communication (peer review comments on draft paper). Beijing, April 2026.
People’s Republic of China (PRC). 2024. 1.334 bln people covered by China's basic medical insurance. [Online] Available at: https://english.www.gov.cn/archive/statistics/202404/12/content_WS661876d0c6d0868f4e8e5f5b.html [accessed: 19 February 2026].
Republic of South Africa (RSA). 1996. The Constitution of the Republic of South Africa, 1996. Pretoria: Government Printer.
Stokes, G. 2026. Oh, to be a fly on the wall in government’s NHI situation room. [Online] Available at: https://www.fanews.co.za/article/talked-about-features/25/straight-talk/1146/oh-to-be-a-fly-on-the-wall-in-government-s-nhi-situation-room/43397 [accessed: 8 April 2026].
Swanepoel, D. 2026. National Health Insurance study visit to China and dialogue with Chinese Health Sector experts. Beijing, 28 January 2026.
World Bank. 2016. Deepening Health Reform in China. [Online] https://openknowledge.worldbank.org/server/api/core/bitstreams/ab618635-7f02-5459-bfd1-cee55d848960/content. [accessed: 19 February 2026].
Yip, W. et al. 2019. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage, The Lancet, 394(10204), pp. 1192–1204.
This report has been published by the Inclusive Society Institute
The Inclusive Society Institute (ISI) is an autonomous and independent institution that functions independently from any other entity. It is founded for the purpose of supporting and further deepening multi-party democracy. The ISI’s work is motivated by its desire to achieve non-racialism, non-sexism, social justice and cohesion, economic development and equality in South Africa, through a value system that embodies the social and national democratic principles associated with a developmental state. It recognises that a well-functioning democracy requires well-functioning political formations that are suitably equipped and capacitated. It further acknowledges that South Africa is inextricably linked to the ever transforming and interdependent global world, which necessitates international and multilateral cooperation. As such, the ISI also seeks to achieve its ideals at a global level through cooperation with like-minded parties and organs of civil society who share its basic values. In South Africa, ISI’s ideological positioning is aligned with that of the current ruling party and others in broader society with similar ideals.
Email: info@inclusivesociety.org.za
Phone: +27 (0) 21 201 1589
Comments